Clearpoint Neuro, Inc. (CLPT)
NASDAQ:CLPT
Want to see CLPT full AI Analyst Report?
Earnings Data
Report Date
Aug 11, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.29Last Year’s EPS
-0.21Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented a predominantly positive commercial and strategic update: record Q1 revenue (+43% YoY), improved gross margin (64%), significant product and regulatory milestones (PRISM expansion, Velocity drill FDA clearance and CE marking), and visible IRRAflow integration progress and synergies. These positives are tempered by meaningful near-term cash reduction and a $8M operational burn in Q1 plus elevated operating expenses (R&D +34%, S&M +75%, G&A +22%) largely tied to growth investments and integration. Management forecasts a return to improved cash consumption as integration completes and reiterated full-year revenue guidance of $52M–$56M. Regulatory uncertainty on the biologics side and temporary OUS distribution transitions introduce timing risk for some programs, while biologics/drug delivery revenue remained essentially flat (+2%) this quarter. Overall, the fundamentals and strategic momentum outweigh the near-term financial and operational headwinds.Company Guidance
Record Quarterly Revenue and Strong YoY Growth
Total revenue of $12.1M in Q1 2026 vs $8.5M in Q1 2025, representing 43% year-over-year growth; management also reported 16% organic growth and device-organic growth of 25%.
Capital Equipment and Software Surge
Capital equipment and software revenue rose 177% to $1.4M in Q1 2026 from $0.5M in Q1 2025, driven by increased placements of ClearPoint Navigation Systems, PRISM laser units and IRRAflow control units.
Improved Gross Margin
Gross margin expanded to 64% in Q1 2026, up 4 percentage points from 60% in Q1 2025, primarily due to a decrease in excess and obsolete inventory reserves.
IRRAflow Acquisition Driving Scale and Synergies
IRRAflow contributed to company-wide growth (including $2.1M in IRRAflow disposable revenue in Q1), management reported most post-merger integration costs are behind them and expects meaningful revenue and cost synergies with potential cash neutrality of the IRRAflow addition as early as 2027.
Expanding Commercial Footprint and Partner Network
More than 175 active sites using ClearPoint technology (targeting >200 by end of 2026), over 60 active biopharma partners, 25+ clinical trials across 15+ indications, and more than 10 partner programs under some form of FDA expedited review.
Regulatory and Product Milestones
FDA clearance (U.S.) and CE marking (Europe) received for the Velocity Alpha MR high-speed surgical drill; full market release of PRISM Laser System and iCT solution; first 3.x platform case in Europe and anticipated first Canadian clinical cases.
Guidance and Forward Outlook
Management reaffirmed 2026 revenue guidance of $52M–$56M and noted Q1 cash burn came in on budget; expect all four core business pillars to grow double digits in 2026 (excluding future commercial cell & gene therapy revenue).
CLPT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
CLPT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 13, 2026 | $12.19 | $12.77 | +4.76% |
Mar 17, 2026 | $11.16 | $9.61 | -13.93% |
Nov 06, 2025 | $18.23 | $15.81 | -13.27% |
Aug 12, 2025 | $10.54 | $11.92 | +13.09% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Clearpoint Neuro, Inc. (CLPT) report earnings?
Clearpoint Neuro, Inc. (CLPT) is schdueled to report earning on Aug 11, 2026, After Close (Confirmed).
What is Clearpoint Neuro, Inc. (CLPT) earnings time?
Clearpoint Neuro, Inc. (CLPT) earnings time is at Aug 11, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CLPT EPS forecast?
CLPT EPS forecast for the fiscal quarter 2026 (Q2) is -0.29.